NCT01064648 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 45
- group Id
- BG002
- value
- 47
- group Id
- BG003
- value
- 112
- units
- Participants
- groups
- description
- All participants from Phase I
- id
- BG000
- title
- Phase I All Participants
- description
- Patients receive pemetrexed disodium IV over 10 minutes and cisplatin IV over 2 hours on day 1 and cediranib maleate PO QD on days 1-21. Treatment repeats every 21 days for 6 courses in the absence of disease progression or unacceptable toxicity. Patients then receive cediranib maleate alone PO QD in the absence of disease progression or unacceptable toxicity. Cediranib Maleate: Given orally Cisplatin: Given IV Laboratory Biomarker Analysis: Correlative studies Pemetrexed Disodium: Given IV
- id
- BG001
- title
- Phase II Cisplatin-pemetrexed Cediranib 20mg
- description
- Patients receive pemetrexed disodium IV over 10 minutes and cisplatin IV over 2 hours on day 1 and placebo PO QD on days 1-21. Treatment repeats every 21 days for 6 courses in the absence of disease progression or unacceptable toxicity. Patients then receive placebo alone PO QD in the absence of disease progression or unacceptable toxicity. Placebo: Given orally Cisplatin: Given IV Laboratory Biomarker Analysis: Correlative studies Pemetrexed Disodium: Given IV
- id
- BG002
- title
- Phase II Cisplatin-pemetrexed Placebo
- description
- Total of all reporting groups
- id
- BG003
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 43.6
- upper Limit
- 83.6
- value
- 64.4
- group Id
- BG001
- lower Limit
- 45.5
- upper Limit
- 82.1
- value
- 71.3
- group Id
- BG002
- lower Limit
- 50.9
- upper Limit
- 85.3
- value
- 71.8
- group Id
- BG003
- lower Limit
- 43.6
- upper Limit
- 85.3
- value
- 69.8
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 19
- title
- Female
- measurements
- group Id
- BG000
- value
- 15
- group Id
- BG001
- value
- 38
- group Id
- BG002
- value
- 40
- group Id
- BG003
- value
- 93
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 6
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 19
- group Id
- BG001
- value
- 41
- group Id
- BG002
- value
- 44
- group Id
- BG003
- value
- 104
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 2
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 2
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 6
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 15
- group Id
- BG001
- value
- 43
- group Id
- BG002
- value
- 42
- group Id
- BG003
- value
- 100
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 4
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 19
- group Id
- BG001
- value
- 42
- group Id
- BG002
- value
- 44
- group Id
- BG003
- value
- 105
- title
- 0-1
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 7
- title
- 2
- description
- Patients will be graded according to the Zubrod Performance Status Scale: 0: Fully active, able to carry on all pre-disease performance without restriction. 1. Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work. 2. Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours. The higher grade is, the worse performance status is.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Zubrod Performance Status
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 18
- group Id
- BG001
- value
- 34
- group Id
- BG002
- value
- 35
- group Id
- BG003
- value
- 87
- title
- Epitheliod or mesothelioma, NOS
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 11
- group Id
- BG002
- value
- 12
- group Id
- BG003
- value
- 25
- title
- Biphasic or sarcomatoid
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Histology
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 9
- group Id
- BG003
- value
- 22
- title
- Yes
- measurements
- group Id
- BG000
- value
- 15
- group Id
- BG001
- value
- 37
- group Id
- BG002
- value
- 38
- group Id
- BG003
- value
- 90
- title
- No
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Prior history of radiation
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 12
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 21
- title
- Yes
- measurements
- group Id
- BG000
- value
- 17
- group Id
- BG001
- value
- 33
- group Id
- BG002
- value
- 41
- group Id
- BG003
- value
- 91
- title
- No
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Prior history of definitive surgery
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 17
- group Id
- BG001
- value
- 35
- group Id
- BG002
- value
- 40
- group Id
- BG003
- value
- 92
- title
- Measurable
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 20
- title
- Non-measurable
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Measurable Disease per RECIST 1.1
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 19
- group Id
- BG001
- value
- 36
- group Id
- BG002
- value
- 30
- group Id
- BG003
- value
- 85
- title
- Measurable
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 17
- group Id
- BG003
- value
- 27
- title
- Non-measurable
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Measurable Disease per Modified RECIST for Pleural Tumors
- unit Of Measure
- Participants
- population Description
- 117 participants were enrolled, only 112 participants were included in the analysis: 5 patients were either not eligible or not analyzable. Thus these 5 patients were excluded from any analysis.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 45
- group Id
- BG002
- value
- 47
- group Id
- BG003
- value
- 112
- units
- Participants
- groups
- description
- All participants from Phase I
- id
- BG000
- title
- Phase I All Participants
- description
- Patients receive pemetrexed disodium IV over 10 minutes and cisplatin IV over 2 hours on day 1 and cediranib maleate PO QD on days 1-21. Treatment repeats every 21 days for 6 courses in the absence of disease progression or unacceptable toxicity. Patients then receive cediranib maleate alone PO QD in the absence of disease progression or unacceptable toxicity. Cediranib Maleate: Given orally Cisplatin: Given IV Laboratory Biomarker Analysis: Correlative studies Pemetrexed Disodium: Given IV
- id
- BG001
- title
- Phase II Cisplatin-pemetrexed Cediranib 20mg
- description
- Patients receive pemetrexed disodium IV over 10 minutes and cisplatin IV over 2 hours on day 1 and placebo PO QD on days 1-21. Treatment repeats every 21 days for 6 courses in the absence of disease progression or unacceptable toxicity. Patients then receive placebo alone PO QD in the absence of disease progression or unacceptable toxicity. Placebo: Given orally Cisplatin: Given IV Laboratory Biomarker Analysis: Correlative studies Pemetrexed Disodium: Given IV
- id
- BG002
- title
- Phase II Cisplatin-pemetrexed Placebo
- description
- Total of all reporting groups
- id
- BG003
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 43.6
- upper Limit
- 83.6
- value
- 64.4
- group Id
- BG001
- lower Limit
- 45.5
- upper Limit
- 82.1
- value
- 71.3
- group Id
- BG002
- lower Limit
- 50.9
- upper Limit
- 85.3
- value
- 71.8
- group Id
- BG003
- lower Limit
- 43.6
- upper Limit
- 85.3
- value
- 69.8
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 19
- title
- Female
- measurements
- group Id
- BG000
- value
- 15
- group Id
- BG001
- value
- 38
- group Id
- BG002
- value
- 40
- group Id
- BG003
- value
- 93
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 6
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 19
- group Id
- BG001
- value
- 41
- group Id
- BG002
- value
- 44
- group Id
- BG003
- value
- 104
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 2
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 2
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 6
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 15
- group Id
- BG001
- value
- 43
- group Id
- BG002
- value
- 42
- group Id
- BG003
- value
- 100
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 4
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 19
- group Id
- BG001
- value
- 42
- group Id
- BG002
- value
- 44
- group Id
- BG003
- value
- 105
- title
- 0-1
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 7
- title
- 2
- description
- Patients will be graded according to the Zubrod Performance Status Scale: 0: Fully active, able to carry on all pre-disease performance without restriction. 1. Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work. 2. Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours. The higher grade is, the worse performance status is.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Zubrod Performance Status
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 18
- group Id
- BG001
- value
- 34
- group Id
- BG002
- value
- 35
- group Id
- BG003
- value
- 87
- title
- Epitheliod or mesothelioma, NOS
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 11
- group Id
- BG002
- value
- 12
- group Id
- BG003
- value
- 25
- title
- Biphasic or sarcomatoid
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Histology
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 9
- group Id
- BG003
- value
- 22
- title
- Yes
- measurements
- group Id
- BG000
- value
- 15
- group Id
- BG001
- value
- 37
- group Id
- BG002
- value
- 38
- group Id
- BG003
- value
- 90
- title
- No
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Prior history of radiation
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 12
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 21
- title
- Yes
- measurements
- group Id
- BG000
- value
- 17
- group Id
- BG001
- value
- 33
- group Id
- BG002
- value
- 41
- group Id
- BG003
- value
- 91
- title
- No
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Prior history of definitive surgery
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 17
- group Id
- BG001
- value
- 35
- group Id
- BG002
- value
- 40
- group Id
- BG003
- value
- 92
- title
- Measurable
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 20
- title
- Non-measurable
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Measurable Disease per RECIST 1.1
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 19
- group Id
- BG001
- value
- 36
- group Id
- BG002
- value
- 30
- group Id
- BG003
- value
- 85
- title
- Measurable
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 17
- group Id
- BG003
- value
- 27
- title
- Non-measurable
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Measurable Disease per Modified RECIST for Pleural Tumors
- unit Of Measure
- Participants
- population Description
- 117 participants were enrolled, only 112 participants were included in the analysis: 5 patients were either not eligible or not analyzable. Thus these 5 patients were excluded from any analysis.
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle